The CDC published the 2024 immunization schedules in November, several months ahead of the usual timeline. The schedules have been approved by the AAP. The vaccine schedule helps physicians determine which vaccine is best to administer and keep track of a patient’s vaccinations against common infectious diseases.
2024 Immunization Schedules
Among the notable updates are:
- Added 20-valent pneumococcal conjugate vaccine (Prevnar 20), RSV monoclonal antibody (Beyfortus), RSV vaccine (Abrysvo), and meningococcal groups A, B, C, W, Y (Penbraya).
- Deleted bivalent mRNA COVID-19 vaccines, 13-valent pneumococcal conjugate vaccine (Prevnar 13) and meningococcal groups A, C, W, Y conjugate vaccine (Menactra).
- Added a new Addendum section to summarize new and updated ACIP recommendations that will occur after the 2024 immunization schedules are published.
- CDC has developed catch-up guidance job aids to assist healthcare providers in interpreting Table 2 in the child and adolescent immunization schedules.
CPP Resources
Contact CPP at cpp@nationwidechildren.org to access and print CPP’s portfolio of pediatric, adult and OBGYN immunization schedules.
